Diaceutics PLC (AIM:DXRX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
123.00
-2.00 (-1.60%)
Jun 17, 2025, 10:20 AM GMT+1
-0.40%
Market Cap 105.67M
Revenue (ttm) 32.16M
Net Income (ttm) -1.70M
Shares Out 84.53M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE 138.58
Dividend n/a
Ex-Dividend Date n/a
Volume 61,410
Average Volume 110,455
Open 124.00
Previous Close 125.00
Day's Range 120.00 - 126.00
52-Week Range 106.00 - 151.00
Beta 0.80
RSI 40.39
Earnings Date Jun 17, 2025

About Diaceutics

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using p... [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 2005
Employees 199
Stock Exchange London Stock Exchange AIM
Ticker Symbol DXRX
Full Company Profile

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.

Financial Statements

News

There is no news available yet.